Patients with Hb ≤ 60 g/L had higher levels of M protein, β2-MG, and LDH than those with Hb > 60 g/L (P < 0.01), indicating increased tumor burden in MM patients with severe anemia. This evidence concerns the gene GSTM1 and anemia.